EPISODE SUMMARY
How does an expert in pharmacokinetics, whose only exposure to computers was taking one semester of programming in college to meet a language requirement, become an advocate for the new AI-driven style of drug discovery? This week Harry finds out from Mark Eller, who helped to invent Allegra at Hoechst Marion Roussel (now Sanofi), spent 12 years at Jazz Pharmaceuticals; and is now senior vice president of research and development at twoXAR, an AI-driven drug discovery startup.
Great, thanks for sharing this article post. Cool. Marco Lyell
Great post. I will be facing some of these issues as well.. Cameron Hancher
You made certain nice points there. I did a search on the subject matter and found a good number of persons will consent with your blog. Joel Touchard